PhotoniCare Inc.
PhotoniCare, we’re dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools. That’s why we developed the TOMi Scope. To improve clinical outcomes and serve unmet patient and provider needs by translating novel light-based technologies into objective medical practice. At PhotoniCare we obsess about finding a better way. We reject the status quo, re-examining unmet health needs to design tools and technologies that make a real impact on health, especially in children. With OtoSight Middle Ear Scope, our flagship innovation, we’ve re-engineered a proven diagnostic technology — Optical Coherence Tomography (OCT) — to revolutionize the diagnosis, treatment, and monitoring of the middle ear infections that affect 4 out of 5 children and countless adults. While the technology is reminiscent of ultrasound, OCT uses near-infrared light waves instead of sound waves to provide 3-D views inside living tissue that are 10x higher resolution than ultrasound.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Occupational Health
- Market Focus:
- Nationally (across the country)
About us
In ophthalmology, OCT is the gold standard for examining the retina, but the technology is housed in large desktop systems that aren’t suitable for ear exams. PhotoniCare reimagined OCT, fitting this powerful technology into in a hand-held device that allows healthcare providers to see their way to more accurate assessments.
What’s next? The application of light in healthcare is limitless. With a patented imaging platform, PhotoniCare provides growth opportunities beyond otology.
- Peer-reviewed studies demonstrate promise with handheld OCT technology for use in anterior and posterior segments of the eye, the skin, and in the mouth
- Screening applications currently on the roadmap include diabetic retinopathy, age-related macular degeneration, glaucoma, melanoma, basal cell carcinoma, oral cancer, cavities, and pulp integrity in teeth.
- Real-time decision support capabilities, fueled by artificial intelligence, are currently under development.